ASSISTANCE AGREEMENT
AWARD TYPE:[]GRANT (31 USC 63O4) [X]COOPERTIVE AGREEMENT (31USC 6305)
[]ER TRANSACTION (10 USC 2371)
AWARD NO:DAMD17-01-2-0051 EFFECTIVE DATE AWARD AMOUNT Paqe 1 of 10
See Grants officer Xxxxxxx X. Xxxxxx
Signature Date Below $1,515,916.00 Phone(301)619-7l43
Fax(301)000-0000
PROJECT TITLE: Devices For Emergency Hypothermia and military
Applications (01038002)
CFDA
12.420
PERFORMANCE PERIOD:1 September 2001 - 30 PRINCIPAL INVESTIGATOR:
September 2002 (Research ends 31, August 2002) Xxxxx Xxxx, (BSME)
AWARDED AND ADMINISTERED BY: PAYMENTS WILL BE MADE BY: EFT:T
U.S. Army Medical Research Acquisition Activity Army Vendor Pay (000) 000-0000
ATTN: MCMR-AAA-A DFAS-SA-FPA
000 Xxxxxxxx Xx. 000 XxXxxxxxxx Xxxxxx
Xxxx Xxxxxxx Xxxxxxxx 00000-0000 Xxx Xxxxxxx XX 00000-2100
DUNS No:803211812 TIN No: (SEE PARAGRAPH TITLED "PAYMENTS"
FOR INSTRUCTIONS)
AWARDED TO: REMIT PAYMENT TO:
Biocontrol Technology, Inc. Biocontrol Technology, Inc.
000 Xxxxxx Xxxxx 000 Xxxxxx Xxxxx
Xxxxxxx, XX 00000 Xxxxxxx, XX 00000
ACCOUNTING AND APPROPRIATION DATA:
9700130183107481193800000009X4150P1FJMB0DAMD170110275FJMBP1018064
$1,515,916.00
SCOPE OF WORK:
Cooperative Agreement Schedule
A. The amount of $1,515,916.00 (One Million Five Hundred Fifteen
Thousand Nine Hundred Sixteen Dollars) is hereby awarded by the U.S.
Army Medical Research Acquisition Activity (USAMRAA) on behalf of the
United States of America to the above-named organization. The
recipient's statement of work on Page 4 of the proposal dated 9
February 2001 and the revised budget dated 15 August 2001 are
incorporated herein by reference. This award is made under the
authority of 31 U.S.C. 6304 and 10 U.S.C. 23S8.
B. Additiona1Iy, this assistance agreement is subject to the attached
USAMRAA General Terms and Conditions for Assistance Awards.
TOTAL AMOUNT ALLOTTED TO DATE: $1,515,916.00
RECIPIENT GRANTS OFFICER
ACCEPTED BY: UNITED STATES OF AMERICA
______________________________ ________________________________
SIGNATURE SIGNATURE
NAME AND TITLE DATE NAME AND TITLE DATE
Xxxxxx X. Xxxxx
GRANTS OFFICER
Assistance Award No. DAND17-01-2-0051
U. S. ARMY MEDICAL RESEARCH ACQUISITION ACTIVITY
GENERAL TERS AND CONDITIONS FOR ASSISTANCE AWARDS
TABLE OF CONTENTS
1. RECIPIENT RESPONSIBILITY............................. 3
2. ADMINISTRATION AND COST PRINCIPLES.................... 3
3. AWARD MODIFICATION.................................... 4
4. APPROVALS AND OTHER AUTHORIZATIONS.................... 4
5. GOVERNMENT INTERACTION................................ 5
6. PUBLICATION AND ACKNOWLEDGMENT........................ 5
7. RESEARCH TECHNICAL REPORTING REQUIREMENTS............. 6
8. FINANCIAL REPORTING REQUIREMENTS...................... 8
9. ADVANCE PAYMENTS AND FULL FUNDING..................... 9
10. SUSPENSION AND TEPMINATTON............................ 9
11. AWARD CLOSE OUT WITH ADVANCED PAYMENTS................ 10
12. SITE VISITS........................................... 10
13. TITLE TO REAL PROPERTY AND EQUIPMENT (FOR-PROFIT)..... 11
14. FEDERALLY OWNED PROPERTY (FOR-PROFIT)................. 11
15. INTELLECTUAL. PROPERTY (FOR-PROFIT)................... 11
16. PATENTS AND INVENTIONS................................ 11
17. DISPUTES.............................................. 12
18. PROHIBITION OF USE OF HUMAN SUBJECTS.................. 12
19. PROHIBITION OF USE OF HUMAN ANATOMICAL SUBSTANCES..... 12
20. PROHIBITION OF USE OF LABORATORY ANIMALS.............. 13
USAMRAA Terms (NOV 2000) Page 2
Assistance Award No.DAND17-01-2-0051
1. RECIPIENT RESPONSIBILITY (NOV 2000) (USAMRAA)
a. The recipient will bear primary responsibility for the conduct
of the research and will exercise judgment towards attaining the
stated research objectives within the limits of the award's terms and
conditions.
b. The Principal Investigator(s) specified in the award document
will be continuously responsible for the conduct of the research
project and will be closely involved with the research effort. The
Principal Investigator, operating within the policies of the
recipient, is in the best position to determine the means by which the
research may be conducted most effectively.
c. The recipient shall obtain the Grants Officer's prior approval
to change the Principal Investigator, or to continue the research work
during a continuous period of absence in excess of three (3) months,
or a 25% reduction in time devoted to the project by the approved
Principal Investigator.
d. The recipient shall obtain the Grants Officer's prior approval
to change:
(1) the methodology or experiment when such is stated in the
award as a specific objective;
(2) the stated objective of the research effort;
(3) the phenomenon or phenomena under study: or
(4) the approved research protocols.
2. ADMINISRATION AND COST PRINCIPLES (NOV 2000) (USAMRAA)
The following Administrative and Cost Principles, as applicable~
effective the earlier of (i) the start date of this award or (ii) the
date on which the recipient incurs costs to be assessed the award, are
incorporated as part of this award by reference:
a. OMB Circular A-21, `Cost Principles for Educational
Institutions."
b. OMB Circular A-87, "Cost Principles for State, Local and
Indian Tribal Governments.
c. OMB Circular A-102, "Grants and Cooperative Agreements with
State and local Governments."
d. OMB Circular A-110, "Uniform Administrative Requirements for
Grants and Agreements with Institutions of Higher Education,
Hospitals, and Other Nonprofit Organizations."
e. OMB Circular A-122, "Cost Principles for Non-profit
Organizations." {For those nonprofit organizations specifically
exempted from the provisions of OMB Circular A-122, Subpart 31.2 of
the Federal Acquisition Regulations (FAR 48 CFR Subpart 31.2) shall
apply}.
f. OMB Circular A-133, "Audits of states, Local Governments, and
Non-Profit Organizations."
g. Federal Acquisition Regulation, Part 31.2 for Commercial
Organizations.
USAMRAA Terms (NOV 2000) Page 3
Assistance Award No. DAND17-01-2-0051
h. Department of Defense Grant and Agreement Regulations 3210. 6-
R, Parts 32, 33 and 34.
These publications may be obtained from:
Office of Management and Budget
EOB Publications Office
New Executive Office Building
000 00xx Xxxxxx, XX, Xxxx 0000
Xxxxxxxxxx XX 00000 Telephone: (000) 000-0000
These publications may be viewed at:
Website: xxx-xxxxxxx.xxxx.xxx, then click reference library and select.
3. AWARD MODIFICATION (NOV 2000) (USAMRAA)
The only method by which this award may be modified is by a formal,
written modification signed by the Grants Officer. No other
communications, whether oral or in writing, are valid.
4. APPROVALS AND OTHER AUTHORIZATIONS (NOV 2000) (USAMRAA)
a. Prior approvals. All prior approvals required by 0MB Circulars
A-fl, A-87, 402, A-nO, A-122, and A-133 are waived except the
following:
(1) Change in the scope or objectives of the research
project as required by paragraph 1 of these terms and conditions
entitled "Recipient Responsibility."
(2) Any request for additional funding.
(3) Change in key personnel as required by paragraph 1 of
these terms and conditions entitled "Recipient Responsibility."
(4) Exclusive of supplies, material, equipment or general
support services, the award of a subaward to accomplish
substantial programmatic work required in the agreement to be
performed by the prime recipient.
(5) Unless identified in the budget incorporated as a part
of the award, expenditures for individual items of general
purpose equipment and specific purpose equipment costing $5,000
or more.
(6) Unless identified in the proposal, incorporated as part
of the award, expenditure for foreign travel.
b. Preaward Costs. The recipient may incur preaward costs of up
to 90 days prior to the start date of the award agreement. Preaward
costs as incurred by the recipient must be necessary for the effective
and economical conduct of the project, and the costs must be otherwise
allowable in accordance with the appropriate cost principles. preaward
costs are made at the recipient's risk. The incurring of preaward
costs by the recipient does not impose any obligation on the
Government in the absence of appropriations, if an award is not
subsequently made, or if an award is made for a lesser amount than the
recipient expected.
c. Change in performance Period. The recipient may make a one-
time extension to the expiration date of the award for a period up to
12 months, the recipient
USAMRAA Terms (NOV 2000) Page 4
Assistance Award No.DAND17-01-2-0051
shall notify the Grants Officer, in writing, at least 10 days prior to
the expiration date of the award.
d. Unobligated Balances. In the absence of any specific notice
to the contrary, the recipient is authorized to carry forward
unexpended balances to subsequent funding periods of the award
agreement.
5. GOVERNMENT INTERACTION (NOV 2000) (USAMRAA)
The active participants in this award are the U.S. Army Medical
Research and Materiel Command (USAMRMC) and its laboratories
identified herein through the U.S. Army Medical Research Acquisition
Activity. The following USAMRMC Laboratory will be the focus of
cooperative research conducted under this agreement
Telemedicine and Advanced Technology Research Center (TATRC)
U.S. Army Medical Research and Material Command
000 Xxxxx Xxxxxx
Xxxx Xxxxxxx, Xxxxxxxx 00000-0000
6. PUBLICATION AND ACKNOWLEDGMENT (NOV 2000) (USAMRAA)
a. Publication. The recipient is encouraged to publish results of
the research, unless classified, in appropriate journals. One copy of
each paper planned for publication shall be submitted to the technical
representative simultaneously with its submission for publication.
Copies of all publications resulting front the research shall be
forwarded to the Grants Officer as they become available, even though
publication may in fact occur subsequent to the termination date of
this award.
b. Acknowledgment. The recipient agrees that in the release of
information relating to this award such release shall include
statements to the effect that the project or effort depicted was
sponsored by the Department of the Army and shall include:
(i) The Award Number;
(ii) "The U.S. Army Medical Research Acquisition Activity,
000 Xxxxxxxx Xxxxxx, Xxxx Xxxxxxx XX 00000-0000 is the awarding
and administering acquisition office." and;
(iii) A statement that the content of the information does
not necessarily reflect the position or the policy of the
Government, and no official endorsement should be inferred. For
purposes of this article, information includes news releases,
articles, manuscripts, brochures, advertisements, still and
motion pictures, speeches, trade association proceedings, etc.
c. Prior to release to the public, the recipient shall notify the
Grants Officer and the Grants officer's Representative (G0R) of the
following: planned news releases, planned publicity, advertising
material concerning grant/cooperative agreement work, and planned
presentations to scientific meetings. This provision is not intended
to restrict dissemination of research information; the purpose is to
inform the U.S. Army Medical Research and Materiel Command (USAMRMC)
of planned public release of information on USAMRMC-funded research,
in order to adequately respond to inquiries and to be alert to the
possibility of inadvertent release of information which could be taken
out of context.
USAMRAA Terms (NOV 2000) Page 5
Assistance Award No.DAND17-01-2-0051
7. RESEARCH TECHNICAL REPORTING REQUIRMENTS (NOV 2000) (USAMRAA)
Format Requirements for Annual/Final Reports
a. Annual reports must provide a complete summary of the research
accomplishments to date with respect to the approved Statement of
Work. Journal articles can be substituted for detailed descriptions of
specific aspects of the research, but the original articles must be
attached to the report as an appendix and appropriately referenced in
the text. The importance of the report to decisions relating to
continued support of the research can not be overemphasized. A report
shall be submitted within 30 calendar days of the anniversary date of
the award (a final report will be submitted upon completion of the
research (last year of the award)).
b. A final report summarizing the entire research effort, citing
data in the annual reports and appended publications shall be
submitted at the end of the award performance period. The final report
will provide a complete reporting of the research findings, journal
publications can be substituted for detailed descriptions of specific
aspects of the research, but an original copy of each publication must
be attached as an appendix and appropriately referenced in the text.
All final reports must include a bibliography of all publications and
meeting abstracts and a list of personnel ~not salaries) receiving pay
from the research effort,
c. Although there is no page limitation for the reports, each
report shall be of sufficient length to provide a thorough description
of the accomplishments with respect to the approved Statement of Work.
Submission of an original and two copies of the report are required.
Reports shall be forwarded to:
Commander
U.S. Army Medical Research and Materiel Command
ATTN: MCMR-RMI-S
000 Xxxxx Xxxxxx
Xxxx Xxxxxxx, Xxxxxxxx 00000-0000
d. All reports shall have the following elements in this order:
front cover, Standard Form (SF 298), table of contents, introduction,
body, key research accomplishments, reportable outcomes, conclusions,
references, and appendices. Pages shall be consecutively numbered
throughout the report. DO NOT RENUMBER PAGES IN THE APPENDICES BUT DO
INCLUDE THE APPENDICES IN THE PAGE COUNT IN BLOCK 15 ON THE SF 298.
Mark all pages of the report which contain proprietary or unpublished
data that should be protected. DO NOT USE THE WORD "CONFIDENTIAL"
WHEN MARKING DOCUMENTS. Indicate in your letter accompanying the
report that the report contains proprietary or unpublished data, and
that the distribution statement should indicate the limitations of the
report.
FRONT COVER: Sample front cover provided at xxxx://xxxx-
xxx.xxxx.xxx. The Accession Document (AD) Number should remain blank.
STANDARD FORM 298: Sample SF 298 provided at xxxx://xxxx-
xxx.xxxx.xxx. The abstract in Block 13 must state the purpose, scope,
major findings and be an up-to-date report of the progress in terms of
results and significance. Subject terms are keywords that may have
previously assigned to the proposal abstract or are keywords that nay
be significant to the research. The number of pages shall include all
pages that have printed data (including the front cover, SF 298, table
of contents, and all appendices). Please count pages carefully to
ensure legibility and that there are no missing pages as this delays
processing of reports. Page numbers should be typed: please do not
hand number pages.
USAMRAA Terms (NOV 2000) Page 6
Assistance Award No. DAND17-01-2-0051
TABLE OF CONTENTS: Sample table of contents provided at
xxxx://xxxx-xxx.xxxx.xxx.
INTRODUCTION: Narrative that briefly (one paragraph) describes
the subject, purpose and scope of the research.
BODY: This section of the report shall describe the research
accomplishments associated with each task outlined in the approved
Statement of Work. Data presentation shall be comprehensive in
providing a complete record of the research findings for the period of
the report. Appended publications and/or presentations may be
substituted for detailed descriptions but must be referenced in the
body of the report. If applicable, for each task outlined in the
Statement of Work, reference appended publications and/or
presentations for details of result findings and tables and/or
figures. The report shall include negative as well as positive
findings. Include problems in accomplishing any of the tasks.
Statistical tests of significance shall be applied to all data
whenever possible. Figures and graphs referenced in the text may be
embedded in the text or appended. Figures and graphs can also-be
referenced in the text and appended to a publication. Recommended
changes or future work to better address the research topic may also
be included, although changes to the original Statement of Work must
be approved by the Grants Officer. This approval must be obtained
prior to initiating any change to the original Statement of Work.
KEY RESEARCH ACCOMPLISHMENTS: Bulleted list of key research
accomplishments emanating from this research.
REPORTABLE OUTCOMES: Provide a list of reportable outcomes that
have resulted from this research to include:
manuscripts, abstracts, presentations; patents and licenses
applied for and/or issued; degrees obtained that are
supported by this award; development of cell lines, tissue
or serum repositories; infomatics such as databases and
animal models, etc.; funding applied for based on work
supported by this award; employment or research
opportunities applied for and/or received based on
experience/training supported by this award.
CONCLUSIONS: Xxxxxxxxx the results to include the Importance
and/or implications of the completed research and when necessary,
recommend changes on future work to better address the problem. A "so
what section" which evaluates the knowledge as a scientific or medical
product shall also be included in the conclusion of the report.
REFERENCES: List all references pertinent to the report using a
standard journal format (i.e. format used in Science, Military
Medicine, etc.)
APPENDICES: Attach all appendices that contain information that
supplements, clarifies or supports the text. Examples include original
copies of journal articles, reprints of manuscripts and abstracts, a
curriculum vitae, patent applications, study questionnaires, and
surveys, etc.
BINDING: Because all reports are entered into the Department of
Defense Technical Reports database collection and are microfiched, it
is recommended that all reports be bound by stapling the pages
together in the upper left hand corner. fll original reports shall be
legible and contain
USAMRAA Terms (NOV 2000) Page 7
Assistance Award No. DAND17-01-2-0051
original photos/illustrations. Figures shall include figure legends
and be clearly marked with figure numbers.
8. FINANCIAL REPORTING REQUIREMENTS (NOV 2000) (USAMRAA)
The recipient shall submit on a quarterly basis a Standard Form 272,
Federal Cash Transactions Report (form available on web site
xxxx://xxx- xxxxxxx.xxxx.xxx). Each report shall be submitted to the
U.S. Army Medical Research Acquisition Activity, ATTN: MCMR-AAA-A, 000
Xxxxxxxx Xxxxxx, Xxxx Xxxxxxx XX 00000-0000 in accordance with the
following schedule:
Period Covered Due Date
Jan - Mar 15 Apr
Apr - Jun 15 Jul
Jul - Sep 15 Oct
Oct - Dec 15 Jan
9. ADVANCE PAYMENTS AND FULL FUNDING (NOV 2000) (USAMRAA)
a. Payments. Advance payments will be made to the recipient.
b. Electronic Funds Transfer. All advance payments to the
recipient will be made by electronic funds transfer (EFT) . The
recipient shall contact the Defense Finance arid Accounting System
(DFAS) nested on the face page of this award to make arrangements for
EFT. Failure to do so may result in nonpayment.
c. If the recipient fails to perform, the Grants Officer shall
notify DFAS in writing to withhold payments.
d. Advance Payment Schedule
Year One $1,515,916
Amount On or About
$378,979 Upon execution of this award
$378,979 (01 January 2002)
$378,979 (01 April 2002)
$378,979 (01 July 2002)
e. Interest Bearing Account. The recipient shall deposit all
advance payments in an interest bearing account. Interest over the
amount of $250 per year shall be remitted annually to the Department
of Health and Human Services, Payment Management System, P. O. Box
6021, Rockville, MD 20852. A copy of the transmittal letter stating
the amount of interest remitted shall be sent to the U.S. Army Medical
Research Acquisition Activity, ATTN: MCMR-AAA-A, 000 xxxxxxxx Xxxxxx,
Xxxx Xxxxxxx, XX 00000-0000.
10. SUSPENSION AND TERMINATION (NOV 2000) (USAMRAA)
a. The Grants Officer way terminate or suspend in whole or in
part, this agreement by written notice to the recipient upon a finding
that the recipient has failed to comply with the material provisions
of this agreement, if the
USAMRAA Terms (NOV 2000) Page 8
Assistance Award No. DAND17-01-2-0051
recipient materially changes the objective of the agreement, or if
appropriated funds are not available to support the program. However
the Grants Officer may immediately suspend or terminate the award
without prior notice when such action is necessary to protect the
interests of the Government.
b. Additionally this agreement may be terminated by either party
upon written notice to the other party, based upon a reasonable
determination that the project will not produce beneficial results
commensurate with the expenditure of resources. Such written notice
shall be preceded by consultation between the parties. In the event
of a termination, the Government shall have a paid-up license in any
subject invention, copyright work, data or technical data made or
developed under this agreemeny.
c. No costs incurred during a suspension period or after the
effective date of a termination will be allowable, except those costs
which, in the opinion of the Grants Officer, the recipient could not
reasonably avoid or eliminate, or which were otherwise authorized by
the suspension or termination notice, provided such costs would
otherwise be allowable under the terms of the award and the applicable
Federal cost principles. In no event will the total of payments under
a terminated award exceed the amount obligated in this award.
1l. AWARD CLOSE OUT WITH ADVANCE PAYMENTS (NOV 2000) (USAMRAA)
a. The recipient shall submit an original SF 272, Federal Cash
Transactions Report (form available on web site xxxX://xxx-
xxxxxxx.xxxx.xxx), within 30 calendar days following the end of the
final quarter.
b. The following documents shall be submitted within 30 calendar
days following the research ending date:
(1) Final Scientific Report, as listed in Paragraph 7.
(2) Patent Report (DD Form 882, Report of Inventions and
Subcontracts) submit as specified in Paragraph 16. (DD Form 882
can be located on web site xxxx://xxx-xxxxxxx.xxxx.xxx.)
(3) Cumulative listing of only the nonexpendable personal
property acquired with award funds for which title has not been
vested to your institution. (This may be submitted on your
institution's letterhead.)
c. In the event a final audit has not been performed prior to the
closeout of the award, the sponsoring agency will, retain the right to
recover an appropriate amount after fully considering the
recommendations on disallowed costs resulting from the final audit.
12. SITE VISITS (NOV 2000) (USAMRAA)
The Grants officer, through authorized representatives, has the right
at all reasonable times to make site visits to review project
accomplishments and to provide such technical assistance as may be
required. If any site visit is made by the Government representative
on the premises of the recipient or subrecipient, the recipient shall
provide, and shall require its subrecipients to provide, all
reasonable facilities and assistance for the safety and convenience of
the Government representatives in the performance of their duties. All
site visits and evaluation shall be performed in such a manner as will
not unduly interfere with or delay the work.
13. TITLE TO REAL PROPERTY AND EQUIPMENT (FOR-PROFIT) (NOV 2000) (USAMRAA)
USAMRAA Terms (NOV 2000) Page 9
Assistance Award No. DAND17-01-2-0051
Real property and equipment acquired in whole or in part with Federal
funds shall be governed by the DOD Grant and Agreement Regulations
3210.6-R, Paragraph 34.21.
14. FEDERALLY OWNED PROPERTY (FOR-PROFIT) (NOV 2000) (USAMRAA)
Title to Federally owned property remains vested in the Federal
Government, and is subject to the requirements of the DOD Grant and
Agreement Regulations 3210.6-R, Paragraph 34.22.
15. INTELLECTUAL PROPERTY (FOR-PROFIT) (NOV 2000) (USAMRAA)
Rights in technical data, patents, inventions, and computer software
under this award shall be as specified in the DOD Grant and Agreement
Regulations 3210.6-r, Paragraph 34.25.
16. PATENTS AND INVENTIONS (NOV 2000) (USAMRR)
a. The recipient shall use the Interagency Edison through the
Natationa1 Institutes of Health Commons (xxxx://xxx.xxxxxxx.xxx) for
filing of Patent Application and Invention Disclosure. Negative
reports are required and shall be submitted on a DD Form 882 to the
Grants Officer. (DD Form 882 can be located on web site xxxx://xxx-
xxxxxxx.xxxxx.xxx.)
b. Invention reports are due annually and at the end of the
period of the award. Annual reports are due 30 calendar days after
the anniversary date of the award and final reports are due 30
calendar days after the expiration of the award. The award will NOT
be closed out until all invention reporting requirements are met.
17. DISPUTES (NOV 2000) (USAMRAA)
Disagreements regarding issues concerning assistance agreements
between the recipient and the Grants Officer shall, to the maximum
extent possible, be resolved by negotiation and mutual agreement at
the Grants Officer level. If agreement cannot be reached, it is our
policy to use alternative dispute resolution (ADR) procedures that may
either be agreed upon by the Government and the recipient in advance
of the award or may be agreed upon at the time the parties determine
to use ADR procedures. If the parties cannot agree on the use of ADR
procedures, the recipient can submit, in writing, a disputed claim or
issue to the Grants Officer. The Grants Officer will consider the
claim or disputed issue and prepare a written decision within 60 days
of receipt. The Grants Officer's decision will be final. The recipient
may appeal the decision within 90 days after receipt of such
notification, Appeals will be resolved by the Head of the Contracting
Activity. The decision by the Head of the Contracting Activity will
be final and not subject to further administrative appeal. However,
the recipient does not waive any legal remedy, such as formal claims,
under Title 28 United State code 1492, by agreeing to this provision.
19. PROHIBITION OF USE OF HUMAN SUBJECTS (NOV 2000) (USAMRAA)
Notwithstanding any other provisions contained in this award or
incorporated by reference herein, the recipient is expressly forbidden
to use or subcontract for the use of human subjects in any manner
whatsoever. In the performance of this award, the recipient agrees
not to come into contact with, use or employ, or
USAMRAA Terms (NOV 2000) Page 10
Assistance Award No. DAND17-01-2-0051
subcontract for the use or employ of any human subjects for research,
experimentation, tests or other treatment under the scope of work as
set out in the award.
19. PROHIBITION OF USE OF HUMAN ANATOMICAL SUBSTANCES (NOV 2000)
(USAMRAA)
Notwithstanding any other provisions contained in this award or
incorporated by reference herein, the recipient is expressly forbidden
to use or subcontract for the use of human anatomical substances in
any manner whatsoever. In the performance of this award, the
recipient agrees not to come into contact with, use or employ, or
subcontract for the use or employ of any human anatomical substances
for research, experimentation, tests or other treatment under the
scope of work as set out in the award.
20. PROHIBITION OF USE OF LAB0RATORY ANIMALS (NOV 2000) (USAMRAA)
Notwithstanding any other provisions contained in this award or
incorporated by reference herein, the recipient is expressly forbidden
to use or subcontract for the use of laboratory animals in any manner
whatsoever without the express written approval of the Grants Officer.
USAMRAA Terms (NOV 2000) Page
11
